Here’s how the American Red Cross makes money from donated blood

Here’s how the American Red Cross makes money from donated blood


The American Red Cross has long been recognized as the universal symbol of humanitarian services —and it’s an expensive operation.

In 2022, the American Red Cross generated more than $3.2 billion in operating revenue and spent just over $3 billion in expenses the same year, according to its financial statements.

Contributions only make up about a third of the organization’s revenue.

“It’s really sort of the charity of choice,” according to Jake Johnston, a senior research associate at the Center for Economic and Policy Research. “When the White House starts raising money, when the big corporations, the NFL, Hollywood A-listers are raising money for the aftermath of a disaster, it’s most likely targeted toward the American Red Cross.”

But the majority of its revenue, just over $1.8 billion, comes from what its financial statements refer to as “Biomedical services.”

“The American Red Cross essentially collects blood from donors and then as part of the way it raises revenue to recover costs, then sells that blood to about 2,500 hospitals and medical facilities across the country,” said Laurie Styron, CEO and executive director of CharityWatch.

When CNBC inquired about the pricing of these products, the American Red Cross responded that “prices for a unit of red blood cells is proprietary information. The pricing is determined by purchase volumes by blood type, service levels, and delivery requirements as well as other agreed upon terms with a hospital.”

The American Red Cross further clarified that it “does not charge for the blood itself” but is “reimbursed by hospitals and transfusion centers for the costs associated with providing blood products.”

A majority of the American Red Cross’ operating expenses, just over $2 billion, is also spent on collecting blood, according to its financial statements. That’s about $139 million more than the revenue it collects from selling the blood.

Michael Thatcher, CEO of Charity Navigator said, “drawing blood is actually a medical intervention that requires certain levels of certification by the people doing that work, the preservation of that blood, making sure that it stays clean and getting them to all these places. All of that costs money.”

Watch the video above to see how the American Red Cross makes and spends its billions.



Source

Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk
Health

Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk

US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov. 6, 2025. Andrew Caballero-Reynolds | AFP | Getty Images President Donald Trump on Thursday struck landmark deals with Eli Lilly and Novo Nordisk that could mark a turning point in how many people can access […]

Read More
Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows 
Health

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows 

The Omada Health logo is displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images Virtual care company Omada Health on Thursday said it will start prescribing GLP-1s and other obesity drugs and helping patients manage those medications. Omada plans to expand the offerings under its weight management program as its membership grows […]

Read More
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
Health

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming […]

Read More